Shattuck Labs, Inc. (STTK) Institutional Ownership

Ownership Summary

Shattuck Labs, Inc. (NASDAQ:STTK) has 83 institutional investors that have filed 13F reports for the period ending March 2026.

• Collectively, these holders controlled 45.5% of Shattuck Labs's outstanding shares in March 2026, down from 58.5% in December 2025.
• They increased total shares held in Shattuck Labs by 42.79% from last quarter, and the number of investors in STTK increased 9.21% annually.
• Of these 83 funds, 56 grew their exposure to Shattuck Labs, 14 cut back, and 13 maintained positions.
• Altogether, these fund groups held 51.07Mn shares in STTK by March 2026, up by 15.3Mn shares quarter on quarter, and up 19.44Mn shares year over year.
• As of March 31, 2026, the biggest holder of Shattuck Labs is T. Rowe Price Investment Management, Inc. at 9.87Mn shares, representing 8.79% of shares outstanding.
• The largest buyers of Shattuck Labs for the quarter ending March 2026 were T. Rowe Price Investment Management, Inc. (8.0Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.28Mn), PRICE T ROWE ASSOCIATES INC /MD/ (1.78Mn), Ameriprise Financial Inc (894.21K), Aberdeen Group plc (628.14K).
• Top sellers of STTK stock for the quarter ending March 2026 included ADAGE CAPITAL PARTNERS GP, L.L.C. (1.66Mn), Bank Of America Corp /De/ (1.03Mn), 683 Capital Management, LLC (590.0K), TWO SIGMA INVESTMENTS, LP (121.72K), Pathstone Holdings, LLC (83.13K).
• Per Business Quant, the top 10 investors in STTK for the quarter ending March 2026 include T. Rowe Price Investment Management, Inc. (9.87Mn), ORBIMED ADVISORS LLC (6.31Mn), Redmile Group, LLC (5.54Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (4.64Mn), NEXTBio Capital Management LP (3.15Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.28Mn), PRICE T ROWE ASSOCIATES INC /MD/ (1.78Mn), CLARK ESTATES INC/NY (1.48Mn), PINNACLE ASSOCIATES LTD (1.37Mn), Aberdeen Group plc (1.16Mn).